What does Dr. G.Caluwé do?

Dr. G.Caluwé is a specialist medical practice in Zandhoven. Private Limited, started on 31 July 2003, 2 establishments.

What is the address of Dr. G.Caluwé?

The registered office of Dr. G.Caluwé is located at Dennenlaan 48, 2243 Zandhoven.

Is Dr. G.Caluwé still active?

Yes. According to the CBE (16 September 2026) Dr. G.Caluwé is active, legal situation “Normale toestand”, started on 31 July 2003.

Is Dr. G.Caluwé registered on Peppol?

Yes, Dr. G.Caluwé is registered on the Peppol network with ID 0208:0859881640.

What is the enterprise number of Dr. G.Caluwé?

The enterprise number of Dr. G.Caluwé is BE0859881640.

When was Dr. G.Caluwé founded?

Dr. G.Caluwé was founded on 31 July 2003.

Who are the directors of Dr. G.Caluwé?

According to the 2025 annual accounts, the directors of Dr. G.Caluwé are: Gilles Caluwé.

Is Dr. G.Caluwé a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 31 July 2003; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did Dr. G.Caluwé make in 2025?

Dr. G.Caluwé posted a profit after taxes of € 171,238 in financial year 2025.

What is the revenue of Dr. G.Caluwé?

As a small company, Dr. G.Caluwé is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 288,532.

Dr. G.Caluwé (Private Limited) - Zandhoven - BE0859881640

Dossier Dr. G.Caluwé, printed on 16 September 2026 from databakkes.be/en/0859881640/dr-g-caluwe. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. G.Caluwé from Zandhoven, company number BE0859881640, closed financial year 2025 with a result of € 171,238 after tax. For that financial year Dr. G.Caluwé recorded a gross margin of € 288,532 and equity of € 912,054. Compared with financial year 2024, the result moved from € 142,688 to € 171,238. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 13, 2026.

What it is worth Growing

€ 912,054

▲ 23% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 171,238

▲ 20% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 71,283

▼ 23% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 893,454.

People and assets in 2025

Vehicles and equipment

€ 8,465

▼ 86% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 69,121

▲ € 58,643 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 789

▲ 3% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 238,147 Gross margin 2022: € 238,147 First fiscal year in the series	€ 282,990 Gross margin 2023: € 282,990 ▲ 19% vs 2022 (€ 238,147) Favourable step	€ 280,783 Gross margin 2024: € 280,783 ▼ 1% vs 2023 (€ 282,990) Unfavourable step	€ 288,532 Gross margin 2025: € 288,532 ▲ 3% vs 2024 (€ 280,783) Favourable step	▲ 3%
Profit after taxes	€ 137,280 Profit after taxes 2022: € 137,280 First fiscal year in the series	€ 148,952 Profit after taxes 2023: € 148,952 ▲ 9% vs 2022 (€ 137,280) Favourable step	€ 142,688 Profit after taxes 2024: € 142,688 ▼ 4% vs 2023 (€ 148,952) Unfavourable step	€ 171,238 Profit after taxes 2025: € 171,238 ▲ 20% vs 2024 (€ 142,688) Favourable step	▲ 20%
Equity	€ 561,105 Equity 2022: € 561,105 First fiscal year in the series	€ 671,812 Equity 2023: € 671,812 ▲ 20% vs 2022 (€ 561,105) Favourable step	€ 740,816 Equity 2024: € 740,816 ▲ 10% vs 2023 (€ 671,812) Favourable step	€ 912,054 Equity 2025: € 912,054 ▲ 23% vs 2024 (€ 740,816) Favourable step	▲ 23%
Total debts	€ 194,286 Total debts 2022: € 194,286 First fiscal year in the series	€ 227,468 Total debts 2023: € 227,468 ▲ 17% vs 2022 (€ 194,286) Unfavourable step	€ 174,014 Total debts 2024: € 174,014 ▼ 23% vs 2023 (€ 227,468) Favourable step	€ 82,154 Total debts 2025: € 82,154 ▼ 53% vs 2024 (€ 174,014) Favourable step	▼ 53%
Cash	€ 95,090 Cash 2022: € 95,090 First fiscal year in the series	€ 54,537 Cash 2023: € 54,537 ▼ 43% vs 2022 (€ 95,090) Unfavourable step	€ 92,077 Cash 2024: € 92,077 ▲ 69% vs 2023 (€ 54,537) Favourable step	€ 71,283 Cash 2025: € 71,283 ▼ 23% vs 2024 (€ 92,077) Unfavourable step	▼ 23%
Land & buildings	€ 330,140 Land & buildings 2022: € 330,140 First fiscal year in the series	€ 344,705 Land & buildings 2023: € 344,705 ▲ 4% vs 2022 (€ 330,140) Unchanged	€ 325,365 Land & buildings 2024: € 325,365 ▼ 6% vs 2023 (€ 344,705) Unchanged	€ 300,703 Land & buildings 2025: € 300,703 ▼ 8% vs 2024 (€ 325,365) Unchanged	▼ 8%
Retained profit	€ 542,505 Retained profit 2022: € 542,505 First fiscal year in the series	€ 653,212 Retained profit 2023: € 653,212 ▲ 20% vs 2022 (€ 542,505) Favourable step	€ 722,216 Retained profit 2024: € 722,216 ▲ 11% vs 2023 (€ 653,212) Favourable step	€ 893,454 Retained profit 2025: € 893,454 ▲ 24% vs 2024 (€ 722,216) Favourable step	▲ 24%
Dividend	€ 45,626 Dividend 2022: € 45,626 First fiscal year in the series	€ 38,245 Dividend 2023: € 38,245 ▼ 16% vs 2022 (€ 45,626) Unchanged	€ 73,685 Dividend 2024: € 73,685 ▲ 93% vs 2023 (€ 38,245) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 73,685) Unchanged	▼ 100%
Bank debt	€ 127,004 Bank debt 2022: € 127,004 First fiscal year in the series	€ 160,730 Bank debt 2023: € 160,730 ▲ 27% vs 2022 (€ 127,004) Unfavourable step	€ 87,484 Bank debt 2024: € 87,484 ▼ 46% vs 2023 (€ 160,730) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 87,484) Favourable step	▼ 100%
Balance sheet total	€ 755,391 Balance sheet total 2022: € 755,391 First fiscal year in the series	€ 899,281 Balance sheet total 2023: € 899,281 ▲ 19% vs 2022 (€ 755,391) Unchanged	€ 914,829 Balance sheet total 2024: € 914,829 ▲ 2% vs 2023 (€ 899,281) Unchanged	€ 994,208 Balance sheet total 2025: € 994,208 ▲ 9% vs 2024 (€ 914,829) Unchanged	▲ 9%

Key figures of Dr. G.Caluwé, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. G.Caluwé?

What happened at Dr. G.Caluwé in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 13, 2026 New annual accounts for financial year 2025: profit of € 171,238 (▲ 20% vs 2024). Source: NBB ↗
Jan 1, 2021 New establishment in Turnhout. KBO
Jul 31, 2003 New establishment in Zandhoven. KBO
Jul 31, 2003 Start of the company according to the CBE. KBO

In short

From € 137,280 profit in 2022 to € 171,238 profit in 2025.

Paid € 264,694 in corporate taxes since 2022.

Best year ever: 2025, with € 171,238 profit.

Paid out € 157,556 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. G.Caluwé? We notify you, reason included.

Follow Dr. G.Caluwé

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Gilles Caluwé

Dr. G.Caluwé

Behind Dr. G.Caluwé is Gilles Caluwé.

See the full network in the app

Directors

According to the 2025 annual accounts

Gilles Caluwé

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Dennenlaan 48

2243 Zandhoven

2.313.887.191

Rubensstraat 166

2300 Turnhout

Active since 1 January 2021

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0859.881.640
VAT number: BE 0859.881.640
Registered office: Dennenlaan 48, 2243 Zandhoven
Names & denominations: Dr. G.Caluwé
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 31 July 2003
Peppol: Active · Active since 24 Nov 2023
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗